Long-term safety data supports sustained use, and PlexusDx's flat-rate pricing ($189-$289/month depending on compound and tier) makes ongoing treatment financially predictable without dose-based cost increases
If you fit any of the criteria below, you are likely to be eligible for the treatment: You are an adult with a BMI (body mass index) of 30 or higher, indicating obesity
Weight changes are gradual and may continue over several months
Comparison with other glucose-lowering agents, comprising sulfonylurea, dipeptidyl peptidase 4 inhibitors (DPP4-I) and SGLT2i are summarized in Supplementary Material 5
Medical supervision with individualized GLP-1 dosing also reduces the risk of dramatic loss of facial fat pads.
GLP-1 RAs in MASH: Mechanisms of Action Although primarily used for the management diabetes and obesity, recent research indicates that GLP-1 RAs may also offer benefits to liver health